Reaction

Immobilisation Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 208 reports · 7 co-occurring drugs

As of the last recalculation, Immobilisation Syndrome appears in 208 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 143.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Baricitinib13143.9144.1
Inclisiran9117.3117.5
Anakinra1490.590.5
Febuxostat Tablets 40 Mg881.881.9
Febuxostat Tablets 80 Mg881.881.9
Lubiprostone776.676.7
Tolvaptan642.542.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.